Medicare Enrolled
Dr. Sam Moskowitz, MD
Gastroenterology · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Moskowitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moskowitz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Moskowitz
Dr. Sam Moskowitz is a gastroenterology specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Moskowitz performed 2,117 Medicare services across 1,038 unique beneficiaries.
Between the years covered by Open Payments, Dr. Moskowitz received a total of $292,497 from 41 pharmaceutical and/or device companies across 1376 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moskowitz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in NY
$292,497 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,117
Medicare services
Top 7% in NY for gastroenterology
1,038
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~106 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
497 | $32 | $194 |
| Special tissue stain and interpretation A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings. |
400 | $11 | $153 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
276 | $38 | $75 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
186 | $30 | $155 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
149 | $23 | $153 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
109 | $53 | $130 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
96 | $165 | $632 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
88 | $50 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $79 | $107 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
68 | $88 | $616 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
39 | $141 | $744 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
26 | $97 | $161 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
25 | $203 | $801 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
20 | $24 | $189 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
12 | $27 | $400 |
| Rectal and anal tone and sensation test A physical examination to assess muscle tone and sensory function in the rectum and anus. |
12 | $448 | $750 |
| Rectal sensitivity and function study A test to evaluate the sensitivity and functional performance of the rectum. |
12 | $182 | $750 |
| Injection beneath large bowel lining via endoscope A flexible endoscope is used to inject medication or fluid beneath the lining of the large intestine. |
11 | $14 | $690 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $96 | $135 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$292,497
Total received (2018-2024)
Avg $41,785/year across 7 years
Top 1% in NY for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
1,376
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$268,443 (91.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,266 (5.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,788 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$65,625
2023
$36,095
2022
$42,377
2021
$23,630
2020
$19,312
2019
$49,341
2018
$56,118
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$24,426
PFIZER INC.
$17,589
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$11,856
Eli Lilly and Company
$5,758
Phathom Pharmaceuticals, Inc.
$4,835
Janssen Biotech, Inc.
$172
Regeneron Healthcare Solutions, Inc.
$160
IRONWOOD PHARMACEUTICALS, INC
$152
Celgene Corporation
$147
Gilead Sciences, Inc.
$147
E.R. Squibb & Sons, L.L.C.
$135
Lilly USA, LLC
$103
RedHill Biopharma Inc.
$54
Madrigal Pharmaceuticals
$28
Novo Nordisk Inc
$24
Merck Sharp & Dohme LLC
$21
Ardelyx, Inc.
$16
Top 3 companies account for 82.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$72,523
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$63,765
Gilead Sciences, Inc.
$50,454
AbbVie, Inc.
$43,464
PFIZER INC.
$19,316
AbbVie Inc.
$12,938
Ferring Pharmaceuticals Inc.
$8,192
Eli Lilly and Company
$5,758
Phathom Pharmaceuticals, Inc.
$4,848
RedHill Biopharma Inc.
$3,164
Ardelyx, Inc.
$1,455
Intuitive Surgical, Inc.
$886
Takeda Pharmaceuticals U.S.A., Inc.
$858
Janssen Biotech, Inc.
$745
Celgene Corporation
$681
Ironwood Pharmaceuticals, Inc
$618
Concordia Pharmaceuticals Inc.
$368
Allergan Inc.
$366
Synergy Pharmaceuticals Inc
$302
E.R. Squibb & Sons, L.L.C.
$240
Evoke Pharma, Inc.
$235
Regeneron Healthcare Solutions, Inc.
$182
IRONWOOD PHARMACEUTICALS, INC
$178
Janssen Scientific Affairs, LLC
$125
INTERCEPT PHARMACEUTICALS, INC.
$122
Braintree Laboratories, Inc.
$121
Lilly USA, LLC
$103
Novo Nordisk Inc
$64
Intercept Pharmaceuticals, Inc.
$54
Intra-Sana Laboratories
$50
Merck Sharp & Dohme Corporation
$48
Romark Laboratories, LC
$45
Merck Sharp & Dohme LLC
$41
Shionogi Inc
$38
Boston Scientific Corporation
$34
Madrigal Pharmaceuticals
$28
CSL Behring
$23
GlaxoSmithKline, LLC.
$21
Endo Pharmaceuticals Inc.
$19
Alfasigma USA, Inc.
$13
Daiichi Sankyo Inc.
$11
Top 3 companies account for 63.8% of all-time payments
Associated products mentioned in payments ›
APRISO · Alinia · Amitiza · BYSTOLIC · CIMZIA · CLENPIQ · CREON · Creon · DIFICID · DONNATAL · DOPTELET · DUPIXENT · Da Vinci Surgical System · Dexilant · Donnatal · ENTYVIO · Entyvio · Epclusa · GATTEX · GIMOTI · GLYCATE · HUMIRA · Humira · IBSRELA · INFLECTRA · INJECTAFER · Kcentra · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · Mavyret · Motegrity · Movantik · Mulpleta · NASCOBAL · OCALIVA · OMVOH · Ozempic · PLENVU · RELISTOR · REMICADE · RESMETIROM · RINVOQ · Rybelsus · SHINGRIX · SKYRIZI · STELARA · SUPREP BOWEL PREP · SUTAB · Symproic · TALICIA · TREMFYA · TRULANCE · Talicia · Trulance · VELSIPITY · VIBERZI · VOQUEZNA · VRAYLAR · Varithena Administration Pack · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for gastroenterology in NY.
Geographic Context
Gastroenterologists within 10 mi
1,170
Per 100K population
44.2
County median income
$78,548
Nearest hospital
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Moskowitz is a clinical cardiology specialist, with above-average Medicare volume (top 7% in NY), with speaking/promotional industry engagement in the top 1% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Moskowitz experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Moskowitz performed 497 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moskowitz receive payments from pharmaceutical companies?
Yes. Dr. Moskowitz received a total of $292,497 from 41 companies across 1,376 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moskowitz's costs compare to other gastroenterologists in Brooklyn?
Dr. Moskowitz's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moskowitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Brooklyn
Browse gastroenterologists in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in NY
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in NY
Which NY gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology